Novo Nordisk AS (N1VO34)

Currency in BRL
32.65
-3.82(-10.47%)
Closed·
N1VO34 Scorecard
Full Analysis
Management has been aggressively buying back shares
Unusual trading volume
Fair Value
Day's Range
32.6534.62
52 wk Range
32.65100.00
Key Statistics
Bid/Ask
32.18 / 34.59
Prev. Close
36.47
Open
34.44
Day's Range
32.65-34.62
52 wk Range
32.65-100
Volume
243.38K
Average Volume (3m)
45.99K
1-Year Change
-65.09%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
N1VO34 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 7 consecutive years

Novo Nordisk AS News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Novo Nordisk AS Company Profile

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Employees
77406
Market
Brazil

Compare N1VO34 to Peers and Sector

Metrics to compare
N1VO34
Peers
Sector
Relationship
P/E Ratio
13.3x17.4x−0.5x
PEG Ratio
0.77−0.480.00
Price/Book
10.1x1.7x2.6x
Price / LTM Sales
4.6x2.3x3.2x
Upside (Analyst Target)
-10.3%43.8%
Fair Value Upside
Unlock16.0%8.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 23.51%
Dividend Yield
2.57%
Industry Median 2.71%
Annualised payout
0.84
Paid unevenly
5-Years Growth
+22.25%
Growth Streak

Earnings

Latest Release
May 07, 2025
EPS / Forecast
6.53 / --
Revenue / Forecast
78.09B / --
EPS Revisions
Last 90 days

N1VO34 Income Statement

People Also Watch

33.70
BBSE3
+0.21%
20.70
NVDC34
-0.81%
32.64
PETR4
-0.40%
38.99
DIRR3
-1.32%
80.66
EMBR3
+5.78%

FAQ

What Stock Exchange Does Novo Nordisk AS Trade On?

Novo Nordisk AS is listed and trades on the B3 Stock Exchange stock exchange.

What Is the Stock Symbol for Novo Nordisk AS?

The stock symbol for Novo Nordisk AS is "N1VO34."

What Is the Novo Nordisk AS Market Cap?

As of today, Novo Nordisk AS market cap is 1.20T.

What Is Novo Nordisk AS's Earnings Per Share (TTM)?

The Novo Nordisk AS EPS (TTM) is 23.51.

From a Technical Analysis Perspective, Is N1VO34 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Novo Nordisk AS Stock Split?

Novo Nordisk AS has split 1 times.

How Many Employees Does Novo Nordisk AS Have?

Novo Nordisk AS has 77406 employees.

What is the current trading status of Novo Nordisk AS (N1VO34)?

As of 01 Aug 2025, Novo Nordisk AS (N1VO34) is trading at a price of 32.65, with a previous close of 36.47. The stock has fluctuated within a day range of 32.65 to 34.62, while its 52-week range spans from 32.65 to 100.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.